To explore the value of contrast-enhanced ultrasound (CEUS) in the diagnosis of breast cancer with neoadjuvant chemotherapy.
Methods:
A nude mouse model of human breast cancer was established
and the clinical drug administration program was simulated. After chemotherapy
the data of tumor biology
ultrasound imaging and blood vessel microcirculation index were measured.
Results:
Tumor vascular endothelial growth factor receptor 1 (VEGFR-1) showed a significant decrease after the early stage of chemotherapy
and the microvascular density (MVD) decreased significantly after the second chemotherapy. The peak intensity (IMAX) of tumor perfusion significantly decreased after the early stage of chemotherapy
and the time to peak (TTP) significantly increased after the second chemotherapy.
Conclusion:
The changes in some indexes of CEUS are c
onsistent with the changes in some tumor microcirculation indexes
although the correlation between them has not been confirmed and needs further research.